The application of physiologically based pharmacokinetic modelling in the analysis of occupational exposure to perchloroethylene

被引:5
|
作者
Loizou, GD [1 ]
机构
[1] Hlth & Safety Lab, Sheffield S3 7HQ, S Yorkshire, England
关键词
perchloroethylene; occupational; exposure; PBPK; modeling;
D O I
10.1016/S0378-4274(00)00283-6
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
A physiologically based pharmacokinetic model for perchloroethylene was parameterized, calibrated and validated using anatomic, physiologic, biochemical and physicochemical data obtained from the literature. The model was used to analyse human exposure data obtained under controlled conditions and from dry cleaning establishments in the Padua area of northern Italy. Whilst the model satisfactorily simulated the urinary excretion of trichloroacetic acid, following experimental inhalation exposure to 10, 20 and 40 ppm perchloroethylene under controlled conditions the opposite was true for the occupational exposure data. However, further model refinement to incorporate inter-individual variability of anatomical, physiological and biochemical parameters which have an impact on model output, would further improve the predictive capabilities of the model. The possibility of perchloroethylene and trichloroethylene co-exposure in the occupational setting was indicated by the model. Crown Copyright (C) 2001 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 50 条
  • [41] Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach
    Li, Sanwang
    Xie, Feifan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (04) : 1402 - 1412
  • [42] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING FOR PREDICTION OF BUPRENORPHINE EXPOSURE IN SUBJECTS WITH HEPATIC IMPAIRMENT (HI)
    Rowland-Yeo, K.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S19 - S19
  • [43] Using population physiologically based pharmacokinetic modeling to determine optimal sampling times and to interpret biological exposure markers: The example of occupational exposure to styrene
    Verner, Marc-Andre
    McDougall, Robin
    Johanson, Gunnar
    TOXICOLOGY LETTERS, 2012, 213 (02) : 299 - 304
  • [44] Physiologically based pharmacokinetic modelling to guide drug delivery in older people
    Chetty, Manoranjenni
    Johnson, Trevor N.
    Polak, Sebastian
    Salem, Farzaneh
    Doki, Kosuke
    Rostami-Hodjegan, Amin
    ADVANCED DRUG DELIVERY REVIEWS, 2018, 135 : 85 - 96
  • [45] Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
    Miroslav Dostalek
    Iain Gardner
    Brian M. Gurbaxani
    Rachel H. Rose
    Manoranjenni Chetty
    Clinical Pharmacokinetics, 2013, 52 : 83 - 124
  • [46] Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
    Dostalek, Miroslav
    Gardner, Iain
    Gurbaxani, Brian M.
    Rose, Rachel H.
    Chetty, Manoranjenni
    CLINICAL PHARMACOKINETICS, 2013, 52 (02) : 83 - 124
  • [47] Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
    De Sutter, Pieter-Jan
    Rossignol, Phebe
    Breens, Lien
    Gasthuys, Elke
    Vermeulen, An
    PHARMACEUTICS, 2023, 15 (09)
  • [48] Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
    Amice, Basile
    Ho, Harvey
    Zhang, En
    Bullen, Chris
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [49] Physiologically based pharmacokinetic modelling in pregnancy: Model reproducibility and external validation
    Silva, Larissa L.
    Silvola, Rebecca M.
    Haas, David M.
    Quinney, Sara K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (04) : 1441 - 1451
  • [50] Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans
    Kinvig, Hannah
    Rajoli, Rajith K. R.
    Pertinez, Henry
    Vora, Lalitkumar K.
    Volpe-Zanutto, Fabiana
    Donnelly, Ryan F.
    Rannard, Steve
    Flexner, Charles
    Siccardi, Marco
    Owen, Andrew
    PHARMACEUTICS, 2023, 15 (12)